Nancy Simonian, Director at Seagen, holds 4.00K shares in Syros Pharmaceuticals (Ticker: SYRS), holds 0.00 shares in Seagen (Ticker: SGEN), holds ― shares in Evelo Biosciences (Ticker: EVLO). Most recently, Nancy Simonian Sold ― shares of Syros Pharmaceuticals on Dec 04, 2024 for an estimated value of 10.01K.
Nancy Simonian latest transaction was an Informative Sell of $10.01K.
What was Nancy Simonian's most profitable transaction?
Nancy Simonian’s most profitable transaction was an Informative Sell of SYRS stock on November 27, 2024. The return on the trade was 25.00%.
What is Nancy Simonian's role in Seagen?
Nancy Simonian's role in Seagen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.